prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
39111,2.12155001000e+17,79926020,0,Rituximab 10mg/ml concentrated intravenous infusion,Rituximab,10mg/ml,Concentrate For Intravenous Infusion,,Drugs Affecting The Immune Response - Rituximab And Alemtuzumab/Cytokine Modulators In Rheumatic Disease,April 2009,8827001,,,,,,,,,1,8020300
55815,9188211000001108,89082020,4,MabCampath 30mg/1ml concentrate for solution for infusion vials (Genzyme Therapeutics Ltd),Alemtuzumab,30mg/1ml,Solution for infusion,Intravenous,Drugs Affecting The Immune Response - Rituximab And Alemtuzumab,August 2013,13120001,,,,,,,,,0,8020300
47502,7695711000001104,89377020,0,MabThera 100mg/10ml concentrate for solution for infusion vials (Roche Products Ltd),Rituximab,10mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Drugs Affecting The Immune Response - Rituximab And Alemtuzumab/Cytokine Modulators In Rheumatic Disease,July 2012,13271001,,,,,,,,,2,8020300
28490,3.59347110000e+16,89371020,275,Rituximab 100mg/10ml solution for infusion vials,Rituximab,10mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Drugs Affecting The Immune Response - Rituximab And Alemtuzumab/Cytokine Modulators In Rheumatic Disease,February 2009,13268001,,,,,,,,,2,8020300
72094,3.41656110000e+16,75829021,4,Truxima 500mg/50ml concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd),Rituximab,10mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Drugs Affecting The Immune Response - Rituximab And Alemtuzumab/Cytokine Modulators In Rheumatic Disease,May 2018,75829021,,,,,,,,,2,8020300
36294,3.59348110000e+16,89375020,30,Rituximab 500mg/50ml solution for infusion vials,Rituximab,10mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Drugs Affecting The Immune Response - Rituximab And Alemtuzumab/Cytokine Modulators In Rheumatic Disease,February 2009,13270001,,,,,,,,,2,8020300
42273,9188011000001102,89080020,1,Alemtuzumab 30mg/1ml solution for infusion vials,Alemtuzumab,30mg/1ml,Solution for infusion,Intravenous,Drugs Affecting The Immune Response - Rituximab And Alemtuzumab,May 2010,13119001,,,,,,,,,0,8020300
73503,3.46343110000e+16,77386021,1,Rixathon 100mg/10ml concentrate for solution for infusion vials (Sandoz Ltd),Rituximab,10mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Drugs Affecting The Immune Response - Rituximab And Alemtuzumab/Cytokine Modulators In Rheumatic Disease,October 2018,77386021,,,,,,,,,2,8020300
74553,3.46137110000e+16,77931021,1,Truxima 100mg/10ml concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd),Rituximab,10mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Drugs Affecting The Immune Response - Rituximab And Alemtuzumab/Cytokine Modulators In Rheumatic Disease,January 2019,77931021,,,,,,,,,2,8020300
